Lynn Gold, PhD, Vice President of CMC Services

Dr. Gold has over 18 years of experience in the pharmaceutical industry with an extensive background in defining regulatory strategies to achieve corporate goals and moving early stage drug development programs to global regulatory submission and commercial launch.  At Camargo, Dr. Gold oversees API synthesis, delivery of CTM (formulation, manufacturing, analytical testing, packaging, stability) and the coordination of chemistry, manufacturing and controls (CMC) information into regulatory filings.

Prior to joining Camargo, Dr. Gold held the position of vice president of research and process development at Sonus Pharmaceuticals located in Seattle, Washington, and was formerly the senior manager of pharmaceutics at Warner Chilcott Laboratories, a division of Galen Holdings, Inc., in Rockaway, New Jersey.  She holds a PhD in physical organic chemistry from the University of Rochester and held a postdoctoral position at Duke University’s Department of Chemistry studying the hydrophobic control of stereochemistry.